Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
David E Lazar
AddedMar 31, 2024
UpdatedMay 31, 2026
David E Lazar

David E Lazar

Board Member, One 4 Art

LinkedIn

David E Lazar's Career

One 4 Art
One 4 Art

Henderson, NV, US

Board Member· Board
Petrone Worldwide
Petrone Worldwide

Henderson, NV, US

Board Member· Board
Titan Pharmaceuticals
Titan Pharmaceuticals

South San Francisco, CA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

David E Lazar's Career

One 4 Art
One 4 Art
22011Henderson, NV, US
Board Member· Board

Similar to One 4 Art

PartsMarketPartsMarketSan Francisco, CA, USAuto Partsest. 2013PartsMarketSan Francisco, CA, US · est. 2013

PartsMarket: Your trusted online source for top-quality auto parts from licensed dismantlers.

Seed · $5M30
PartsCargoPartsCargoNew York, USAuto Partsest. 2014PartsCargoNew York, US · est. 2014

PartsCargo: Your go-to e-commerce platform for affordable, quality auto parts and accessories, ensuring a seamless shopping experience.

Pre-Seed · $200k30
Auto Parts 4Less GroupAuto Parts 4Less GroupLas Vegas, NV, USAuto Parts, Truck PartsAuto Parts 4Less GroupLas Vegas, NV, US

Leading e-commerce auto parts company in Las Vegas, Nevada.

Public3
AutopartsZAutopartsZNew York, USCar Parts, Tiresest. 2018AutopartsZNew York, US · est. 2018

AutoPartsZ: Your one-stop online marketplace for car parts, repair estimates, and vehicle reports.

Pre-Seed · $150k5
Petrone Worldwide
Petrone Worldwide
Public51998Henderson, NV, US
Board Member· Board
Titan Pharmaceuticals
Titan Pharmaceuticals
Public$54.2M141992South San Francisco, CA, US
Board Member· Board

Leadership at Titan Pharmaceuticals

David NatanDavid NatanBoard Member
Louis BucaloLouis BucaloFounder
M. David MacFarlaneM. David MacFarlaneBoard Member
Avraham Ben-TzviAvraham Ben-TzviBoard Member

Similar to Titan Pharmaceuticals

Tioga PharmaceuticalsTioga PharmaceuticalsSan Diego, CA, USPharmaceuticalsest. 2005Tioga PharmaceuticalsSan Diego, CA, US · est. 2005

Tioga Pharmaceuticals: Innovating gastrointestinal disease treatments as a leading pharma manufacturer.

Public · $57M30
Theriana PharmaceuticalsTheriana PharmaceuticalsWaltham, MA, USPharmaceuticalsest. 2017Theriana PharmaceuticalsWaltham, MA, US · est. 2017

Theriana Pharmaceuticals: Leading pharmaceutical manufacturer.

Seed · $1.8M5
Terns PharmaceuticalsTerns PharmaceuticalsFoster City, CA, USDrug Developmentest. 2016Terns PharmaceuticalsFoster City, CA, US · est. 2016

Terns Pharmaceuticals: A global biopharmaceutical firm specializing in liver disease and cancer treatments.

Public · $348.3M30

People Similar to David E Lazar

Willix HalimWillix HalimCEO · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakWILL WEI CHENGWILL WEI CHENGBoard Member · DiDiDhirubhai H. AmbaniDhirubhai H. AmbaniBoard Member · Reliance RetailMason YeoMason YeoBoard Member · KakaoJaeHong ChoiJaeHong ChoiBoard Member · Kakao